Inhibition of CCL2, CCL5, or CXCL12 suppresses Th1 cell migration in vitro, suggesting that these chemokines might promote Th1 cell recruitment to the RA synovium (129). This evidence concerns the gene CCL5 and rheumatoid arthritis.